Webinar: Photobiomodulation for Hand and Foot Skin Toxicity Related to Cancer Therapy

    • Via Zoom

      7 July 2022 at 7:30 PM AEST

      Dr Jolien Robijns will present on the topic of Photobiomodulation (PBM) for Hand and Foot Skin Toxicity Related to Cancer Therapy. This webinar will be of particular interest to dermatologists, oncologists and wound care and oncology nurses.

      • Discuss the pathogenesis and risk factors of hand and foot skin toxicity-related to cancer therapy
      • Discuss the staging and standard of care for hand and foot skin toxicity-related to cancer therapy
      • Clinical research on hand and foot skin toxicity-related to cancer therapy
      • Our own experience with PBM and hand and foot skin toxicity-related to cancer therapy

      REGISTER

    • Jolien presented her research at several (inter)national conferences in the field of oncology and PBM. She received up to eleven awards for her research, which has gained attention in the Belgian media. Dr. Robijns is also a member of the MASCC, Belgian Laser Group, WALT, and ASLMS.

    • Presenter: Dr Jolien Robijns, MSc, PhD

      Jolien Robijns obtained her master’s degree in Biomedical Sciences at Hasselt University, Belgium, in 2014. In October 2018, she graduated as a Doctor in Biomedical Sciences at Hasselt University under Prof. Dr. Jeroen Mebis, Head of the Medical Oncology department (Jessa Hospital, Hasselt, BE). Her research focuses on the use of photobiomodulation (PBM) in supportive cancer care. The main topic of her Ph.D. project was the application of PBM for the prevention and management of acute radiodermatitis in cancer patients. She now further investigates the beneficial effects of PBM in an oncologic setting for other indications (e.g., lymphedema, hand-foot syndrome, alopecia, neuropathy, mucositis) as a postdoctoral researcher.

      Since November 2019, the research group under Prof. Mebis has set up the Limburg Oncologic Laser Institute (LOwLIght). The ultimate goal of LOwLIght is to perform more PBM research, enhance the implementation of PBM in clinical practice, and share PBM knowledge.